Article History
Received: 11 April 2024
Accepted: 3 June 2024
First Online: 22 June 2024
Declarations
:
: Ramzi A. Ajjan: received honoraria for presentations and/or consultancy and/or research funding from Abbott Diabetes Care, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Meyers Squibb, Eli Lilly, GlaxoSmithKline, LifeScan, Menarini Pharmaceuticals, Merck-Sharp & Dohme, NovoNordisk, Roche, Sanofi and Takeda. Samuel Seidu: speaker honoraria, advisory board or educational grants: AstraZeneca, Boehringer Ingelheim, Janssen, Eli Lilly, MSD, Abbott, NovoNordisk, SB Communications, OmniaMed, Roche, Napp, NB Medical, Amgen, Sanofi. Jean Pierre Riveline: is an advisory panel member for Sanofi, MSD, Eli Lilly, Novo Nordisk, AstraZeneca, Abbott, Dexcom, Alphadiab, Air Liquide Healthcare and Medtronic and has received research funding from Abbott, Air Liquide Healthcare, Sanofi, and NovoNordisk.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.